US Mendelian Disorders Testing Market Summary
The US Mendelian Disorders Testing market is projected to grow from 0.58 billion USD in 2024 to 1.39 billion USD by 2035, reflecting a robust growth trajectory.
Key Market Trends & Highlights
US Mendelian Disorders Testing Key Trends and Highlights
- The market valuation is expected to increase from 0.58 billion USD in 2024 to 1.39 billion USD by 2035.
- A compound annual growth rate (CAGR) of 8.29 percent is anticipated from 2025 to 2035.
- This growth may be driven by advancements in genetic testing technologies and increased awareness of Mendelian disorders.
- Growing adoption of genetic testing due to rising prevalence of hereditary diseases is a major market driver.
Market Size & Forecast
2024 Market Size | 0.58 (USD Billion) |
2035 Market Size | 1.39 (USD Billion) |
CAGR (2025-2035) | 8.29% |
Major Players
Diagnostic Laboratories, Genetic Testing Companies, Research Institutions